Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin Exp Allergy ; 41(4): 482-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21338428

ABSTRACT

BACKGROUND: There is evidence to suggest that the risk of asthma might be increased with exposure to paracetamol in the intrauterine environment, infancy, later childhood and adult life. OBJECTIVE: To review the evidence from studies investigating the association between paracetamol use in pregnancy and childhood asthma. METHODS: A systematic review and meta-analysis was undertaken of studies reporting the association between paracetamol use in pregnancy and subsequent asthma in childhood. The primary outcome variable was wheeze in the last 12 months. For tabulated raw data, not adjusted for confounders, random effects odds ratios (OR) were pooled by the inverse variance weighted method. RESULTS: There were six studies identified that were included in the meta-analysis. The age of children studied ranged from 30 to 84 months. The pooled random effects OR for the risk of current wheeze in the children of women who were exposed to any paracetamol during any stage of pregnancy was 1.21 (95% confidence interval 1.02-1.44). Features of the studies variably included an association with paracetamol use during all trimesters of pregnancy and an association with persistent asthma, severe asthma, and with atopy. CONCLUSION AND CLINICAL RELEVANCE: The use of paracetamol during pregnancy is associated with an increased risk of childhood asthma. More research is urgently required to determine the impact of paracetamol during pregnancy on the risk of wheezing in offspring so that appropriate public health recommendations can be made.


Subject(s)
Acetaminophen/adverse effects , Analgesics, Non-Narcotic/adverse effects , Asthma/chemically induced , Prenatal Exposure Delayed Effects/chemically induced , Respiratory Sounds/etiology , Asthma/epidemiology , Child , Female , Humans , Pregnancy , Risk Factors
2.
Clin Exp Allergy ; 40(1): 32-41, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20205695

ABSTRACT

Paracetamol use represents a putative risk factor for the development of asthma. There is convincing epidemiological evidence that the risk of asthma may be increased with exposure to paracetamol in the intrauterine environment, infancy, later childhood and adult life. A dose-dependent association has also been observed in these different age groups in different populations world-wide. An association has also been shown between paracetamol use in both rhinoconjunctivitis and eczema. There is biological plausibility with paracetamol use leading to decreased glutathione levels resulting in increased oxidant-induced inflammation and potentially enhanced T-helper type 2 responses. At the population level, patterns of paracetamol use might explain, to some extent, the world-wide variation in the prevalence of asthma and related disorders, particularly the high rates in English-speaking countries, which have high per capita prescription and over-the-counter use of paracetamol. A temporal association also exists between the international trends of increasing paracetamol use and increasing prevalence of asthma over recent decades. Further research is urgently required, in particular randomized-controlled trials (RCTs) into the long-term effects of frequent paracetamol use in childhood, to determine the magnitude and characteristics of any such risk. Importantly, RCTs will also enable evidence-based guidelines for the recommended use of paracetamol to be developed.


Subject(s)
Acetaminophen/adverse effects , Analgesics, Non-Narcotic/adverse effects , Asthma/epidemiology , Asthma/etiology , Prenatal Exposure Delayed Effects/etiology , Adult , Child , Child, Preschool , Female , Global Health , Humans , Infant , Male , Pregnancy , Prenatal Exposure Delayed Effects/epidemiology , Prenatal Exposure Delayed Effects/immunology , Prevalence , Risk Factors , Th2 Cells/immunology
3.
Theor Appl Genet ; 109(3): 488-94, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15067509

ABSTRACT

Two virus resistance loci on linkage groups II and VI have provided the only sources of natural resistance against Pea seed-borne mosaic virus (PSbMV, Potyviridae) in the important crop plant Pisum sativum L. A combination of parallel approaches was used to collate linked markers, particularly for sbm-1 resistance on linkage group VI. We have identified sequences derived from the genes for the eukaryotic translation initiation factors eIF4E and eIF(iso)4E as being very tightly linked to the resistance gene clusters on linkage groups VI and II, respectively. In particular, no recombinants between sbm-1 and eIF4E were found amongst 500 individuals of an F2 cross between the BC4 resistant line (JI1405) and its recurrent susceptible parent 'Scout'. In a different mapping population, the gene eIF(iso)4E was also shown to be linked to sbm-2 on linkage group II. A parallel cDNA-AFLP comparison of pairs of resistant and susceptible lines also identified an expressed tag marker just 0.7 cM from sbm-1. eIF4E and eIF(iso)4E have been associated with resistance to related viruses in other hosts. This correlation strengthens the use of our markers as valuable tools to assist in breeding multiple virus resistances into peas, and identifies potential targets for resistance gene identification in pea.


Subject(s)
Genetic Linkage/genetics , Mosaic Viruses/pathogenicity , Phenotype , Pisum sativum/genetics , Plant Diseases/genetics , Agriculture/methods , Blotting, Southern , Chromosome Mapping , Crosses, Genetic , DNA Primers , DNA, Complementary/genetics , Eukaryotic Initiation Factors/genetics , Genetic Markers/genetics , Pisum sativum/virology , Plant Diseases/virology , Polymorphism, Restriction Fragment Length
4.
Pediatr Rehabil ; 6(2): 103-9, 2003.
Article in English | MEDLINE | ID: mdl-14534047

ABSTRACT

Despite considerable scientific evidence to the contrary, many medical practitioners maintain that children recover from brain injury better than adults. This belief, which is commonly referred to as the "Kennard Principle", has important ramifications for personal injury compensation claims in which the amount of financial damages claimed is partly based on medical experts' prognoses for recovery and long-term outcome. The present study investigated whether legal practitioners' beliefs are consistent with those of medical practitioners. Lawyers were asked to estimate their confidence in consultant neurologists' estimates of recovery in four clinically-based but fictitious case studies which differed only in the reported age of the patient. The lawyers showed more confidence in estimates which coincided with the Kennard Principle than those which did not. These results support previous findings in showing widespread belief that "younger is better" in recovery from brain injury. In consequence, it is likely that financial compensation for children with brain injury is currently being underestimated in litigation, thereby prejudicing the long-term outcome of the child.


Subject(s)
Brain Injuries/rehabilitation , Age Factors , Child, Preschool , Female , Humans , Legislation as Topic , Male , Middle Aged , Surveys and Questionnaires
5.
J Biol Chem ; 269(9): 6417-23, 1994 Mar 04.
Article in English | MEDLINE | ID: mdl-8119991

ABSTRACT

The Rh blood group antigens are associated with nonglycosylated human erythrocyte membrane proteins of molecular mass 30 kDa (the Rh30 polypeptides) and a glycoprotein of 40-100 kDa (the Rh glycoprotein). We have studied the topology of this family of proteins in the erythrocyte membrane. We confirmed the predicted cytosolic localization of the C and N termini of the Rh protein family. We located Lys-196 and Arg-323 of the Rh glycoprotein to the cytosol, and Glu-34 to the extracellular side of the plasma membrane in erythrocytes, by N-terminal sequencing of Rh glycoprotein peptides produced by proteolysis at the cytoplasmic or extracellular side of the membrane. We also show that a glycan chain is present on only one (Asn-37) of the three potential N-glycan addition sites in the Rh glycoprotein. Studies of the Rh glycoprotein fragments that co-immunoprecipitated with the Rh30 polypeptides suggest there is an interaction between the Rh30 polypeptides and amino acids 35-196 of the Rh glycoprotein. A model for the organization of the components of the Rh complex in the red cell membrane is proposed.


Subject(s)
Protein Structure, Secondary , Rh-Hr Blood-Group System/chemistry , Antibodies, Monoclonal , Antibody Specificity , Electrophoresis, Polyacrylamide Gel , Erythrocyte Membrane/metabolism , Erythrocyte Membrane/ultrastructure , Humans , Macromolecular Substances , Models, Structural , Molecular Weight , Trypsin
6.
J Biol Chem ; 269(9): 6410-6, 1994 Mar 04.
Article in English | MEDLINE | ID: mdl-7509803

ABSTRACT

The blood group Rh antigens are associated with non-glycosylated 30-kDa erythrocyte membrane proteins (the Rh30 polypeptides) and the Rh glycoprotein. We used antipeptide antibodies to study the Rh glycoprotein in human erythrocyte membranes. The Rh glycoprotein was present in Rhnull U+ve cells. However, the N-glycan chain of the Rh glycoprotein in Rhnull U+ve cells was smaller than in normal cells. In contrast, the N-glycan chain of the Rh glycoprotein was larger than normal in glycophorin B-deficient red cells. We suggest that this observation reflects a lower rate of movement of newly synthesized Rh glycoprotein through intracellular membranes to the cell surface in the absence of glycophorin B, and that in normal red cells glycophorin B facilitates the movement of the Rh protein complex to the cell surface. Our results provide evidence for the intracellular interaction of at least three proteins, the Rh glycoprotein, Rh30 polypeptides, and glycophorin B during the biosynthesis and cell surface expression of the Rh complex. These observations are likely to be important for the successful design of expression systems for the blood group Rh antigens.


Subject(s)
Erythrocyte Membrane/metabolism , Erythrocytes/metabolism , Rh-Hr Blood-Group System/biosynthesis , Animals , Anion Exchange Protein 1, Erythrocyte/isolation & purification , Anion Exchange Protein 1, Erythrocyte/metabolism , Antibodies , DNA, Complementary/blood , Dogs , Electrophoresis, Polyacrylamide Gel , Epitopes/analysis , Glycophorins/deficiency , Glycophorins/metabolism , Humans , Immunoblotting , Male , Microsomes/metabolism , Molecular Weight , Pancreas/metabolism , Protein Biosynthesis , Rabbits/immunology , Rh-Hr Blood-Group System/blood , Rh-Hr Blood-Group System/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...